Latest Targeted therapy Stories
Innovators of Today Will Join Past Pioneers in Helping Save, Prolong and Improve Lives Plainsboro, NJ (PRWEB) May 20, 2015 Oncologists whose research
Study Did Not Meet Primary or Key Secondary Endpoints SAN DIEGO, May 20, 2015 /PRNewswire/ -- Lpath, Inc.
AURORA, Colorado, May 14, 2015 /PRNewswire/ -- Strand Life Sciences, a global genomic profiling company that uses next generation sequencing technology to empower cancer
17 abstracts include data from: NORTH CHICAGO, Ill., May 11, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced 17 abstracts from studies of the company's oncology pipeline are being presented
-- Journal of Clinical Investigation article highlights Blueprint Medicines' focus on exploiting untapped potential in well-validated field of kinase drug discovery -- CAMBRIDGE, Mass., May
-- AbbVie plans to submit regulatory applications for venetoclax to the U.S.
National Cancer Institute Clinical Trial for TRC105 for Angiosarcoma Santa Monica, Ca (PRWEB) April 30, 2015 The Sarcoma Oncology Center is participating
- 60 percent of surveyed U.S.
$20 million project will combine targeted therapies and immunotherapy PHILADELPHIA, April 20, 2015 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C) and the American Cancer Society
DURHAM, N.C., April 16, 2015 /PRNewswire-iReach/ -- The majority of gastric cancers harbor genomic alterations (GAs) associated with potential benefit from targeted therapies, according to a
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.